Skip to main content
Beth Israel Deaconess Medical Center
Balk Lab
Primary menu
  • About
    • Team
    • Instructors
    • Research Fellows
    • Students
    • Alumni
  • Publications
  • Research
  • News + Updates

Contact

Publications by Year: 1988

1988

Bleicher, P A, and S P Balk. (1988) 1988. “T-Cell Receptor Gene Rearrangements. Progress and Promise.”. Archives of Dermatology 124 (3): 359-63.
Publisher's Version
Publisher's Version

Recent Publications

  • BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress.
  • Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancer.
  • AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer.
  • A carboxy-terminal ubiquitylation site regulates androgen receptor activity.
  • WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth.
  • Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer.

Balk Lab

  • X
Secondary menu
  • About
  • Team
  • Research
  • News
  • Publications
Powered byOpenScholar®Admin Login